Skip to main content
Top

Drugs

Issue 2/2018

Content (10 Articles)

Hypermutated Tumors and Immune Checkpoint Inhibition

  • Leading Article

Kristen K. Ciombor, Richard M. Goldberg

Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment

  • Review Article

Michel Daudon, Vincent Frochot, Dominique Bazin, Paul Jungers

Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000–2016: A Systematic Review and Meta-Analysis

  • Systematic Review

Paola Pansa, Yingfen Hsia, Julia Bielicki, Irja Lutsar, A. Sarah Walker, Mike Sharland, Laura Folgori

Ledipasvir/Sofosbuvir: A Review in Chronic Hepatitis C

  • Adis Drug Evaluation

Lesley J. Scott

Emicizumab-kxwh: First Global Approval

  • AdisInsight Report

Lesley J. Scott, Esther S. Kim

Semaglutide: First Global Approval

  • AdisInsight Report

Sohita Dhillon

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images